Cutaneous toxicity from epidermal growth factor receptor inhibitors: would a subcutaneous desensitization be helpful? Case report. [electronic resource]
Producer: 20170206ISSN:- 2038-2529
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Colorectal Neoplasms -- complications
- Desensitization, Immunologic
- ErbB Receptors -- antagonists & inhibitors
- Female
- Humans
- Immune Tolerance
- Male
- Skin Diseases -- etiology
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.